An Investigational Study Examining the Cross-Validation of QbMobile in ADHD and Normative Populations
Part of paid clinical trials in San Jose, California.
- Sponsor
- Qbtech AB
- Study ID
- NCT07220330
- Status
- Enrolling By Invitation
Conditions
- Attention Deficit Hyperactivity Disorder (ADHD)
- Healthy Volunteer
- No History of ADHD
Eligibility Criteria
- Sex
- ALL
- Age
- 6 Years - 60 Years
- Healthy Volunteers
- Accepted
Interventions
- QbMobile — DEVICEQbMobile is a software application that can be installed on a smartphone device used to measure activity, attention, impulsivity, and movement patterns in participants over a two-day period.
Study Details
The purpose of this study is to investigate QbMobile ability to collect and provide accurate and objective data which can be used to facilitate assessment and treatment procedures for ADHD in a clinical setting as well as remotely.
Key Dates
- Start date
- Jan 15, 2025
- Status verified
- May 2026
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 700 participants (estimated)
Arms
- Arm: This single cohort includes subjects with and without ADHD.Eligible participants that do not have a documented or suspected current or lifetime diagnosis of ADHD will be recruited from the general population using different recruitment activities (letters, posted flyers, etc.). Eligible participants being referred for their initial assessment or have a diagnosis of ADHD but currently not receiving treatment who are attending a clinic visit at study sites will be approached by a clinic research staff about the study or contacted prior to their appointment.
Primary Outcome Measure
Standardized QbMobile Scores of the four parameters: Attention, Impulsivity, Activity, and Movement Patterns. [ Time Frame: 10-minute testing period ]
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Prodigy Psychiatric Group | San Jose | California | 95138 | - |
| Bokhari Medical Consortium | Largo | Florida | 33770 | - |
| Nona Pediatric Center | Orlando | Florida | 32832 | - |
Find similar trials in San Jose, CA
Related Studies
- Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)PHASE1 · Recruiting · Ensysce Biosciences · Miami, Florida
- Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy PatientsPHASE1 · Recruiting · Suninflam Inc · DeLand, Florida
- A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult ParticipantsPHASE1 · Recruiting · AbbVie · Cypress, California
- A First-in-Human Single and Multiple Ascending Dose Study of MT-201PHASE1 · Recruiting · Mirador Therapeutics, Inc. · San Diego, California